Global pharmacovigilance market is estimated to touch a market value of $5,008.2 million in 2019.
Rapid growth of pharmaceutical industries has resulted in innovations and increase in the number of drugs into the market, which has also resulted in rise of adverse drug events and drug related toxicities. These events have led to a rise in public safety concerns, stringent regulatory policies, expectations and tough inspection regimes, providing the much needed stimulation for the growth of pharmacovigilance market. Recently, the scope of drug safety reporting has been extended to medical devices, traditional medicines and biologicss.
Read more: benzinga.com
